Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
post
Last Updated: April 2, 2026, 3:13 am
Author: Getaka|Social: XLinkedIn

Kopran Ltd: Intrinsic Value & Share Price Analysis

Fair Value

₹226.15Undervalued by 90.04%vs CMP ₹119.00

P/E (34.7) × ROE (7.6%) × BV (₹104.00) × DY (2.53%)

₹114.92Fairly Valued by 3.43%vs CMP ₹119.00
MoS: -3.6% (Negative)Confidence: 48/100 (Moderate)Models: 2 Under, 2 Fair, 5 Over
ModelCategoryValueWeightSignal
PE-ROEEarnings₹174.1722%Under (+46.4%)
Graham NumberEarnings₹89.5916%Over (-24.7%)
Earnings PowerEarnings₹34.8313%Over (-70.7%)
DCFCash Flow₹2.2113%Over (-98.1%)
Net Asset ValueAssets₹103.877%Over (-12.7%)
EV/EBITDAEnterprise₹115.069%Fair (-3.3%)
Earnings YieldEarnings₹34.307%Over (-71.2%)
ROCE CapitalReturns₹365.369%Under (+207%)
Revenue MultipleRevenue₹130.615%Fair (+9.8%)
Consensus (9 models)₹114.92100%Fairly Valued
Key Drivers: EPS CAGR -23.0% drags value — could be higher if earnings stabilize. | Wide model spread (₹2–₹365) — high uncertainty.

PE-ROE · Graham · EPV · DCF · NAV · EV/EBITDA · DDM · Earnings Yield · ROCE Capital · Revenue Multiple | CoE: 12% · Terminal: 4% · EPS CAGR: -23.0%

*Investments are subject to market risks

Investment Snapshot

55
Kopran Ltd scores 55/100 (Average)
Based on 5 dimensions: health, institutional flow, earnings quality, momentum, and peer comparison
Stock Health70/100 · Strong
ROCE 9.8% AverageROE 7.6% AverageD/E 0.26 Low debtInterest Coverage 0.0x RiskyProfitable 5/5 years Consistent
Smart Money50/100 · Moderate
FII holding stable No changePromoter holding at 44.4% Stable
Earnings Quality50/100 · Moderate
OPM stable around 12% Steady
Quarterly Momentum40/100 · Moderate
Revenue (4Q): -4% YoY FlatProfit (4Q): -65% YoY Declining
Industry Rank55/100 · Moderate
P/E 34.7 vs industry 53.8 Cheaper than peersROCE 9.8% vs industry 16.4% Below peers3Y sales CAGR: 10% Moderate

Weights: Health 30% · Earnings Quality 25% · Momentum 20% · Industry Rank 15% · Smart Money 10%. Scores are computed from reported financials and recalculated daily. Not investment advice.

Share Price and Basic Stock Data

Last Updated: April 2, 2026, 3:13 am

Market Cap 574 Cr.
Current Price 119
Intrinsic Value₹114.92
High / Low 215/107
Stock P/E34.7
Book Value 104
Dividend Yield2.53 %
ROCE9.75 %
ROE7.64 %
Face Value 10.0
PEG Ratio-1.51

Stock P/E, Current Price, and Intrinsic Value Over Time

View Share Price Target for Kopran Ltd

Competitors

Stock Name ⇩Market Cap ⇩Current Price ⇩High / Low ⇩Stock P/E ⇩Book Value ⇩Dividend Yield ⇩ROCE ⇩ROE ⇩Face Value ⇩
Kopran Ltd 574 Cr. 119 215/10734.7 1042.53 %9.75 %7.64 % 10.0
Kilitch Drugs (India) Ltd 484 Cr. 138 250/11718.6 75.90.00 %15.7 %12.6 % 10.0
Themis Medicare Ltd 683 Cr. 74.2 179/65.0 41.30.67 %10.4 %7.65 % 1.00
Anuh Pharma Ltd 731 Cr. 73.0 115/66.717.5 32.62.06 %17.2 %13.4 % 5.00
SMS Lifesciences India Ltd 357 Cr. 1,197 1,680/95620.6 6500.13 %11.8 %10.8 % 10.0
Industry Average19,815.15 Cr1,053.8453.84201.200.39%16.35%15.16%6.10

All Competitor Stocks of Kopran Ltd

Quarterly Result

MetricDec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Sales 158.00148.88117.00152.59158.92186.08139.44151.56166.24172.36135.22117.91194.28
Expenses 145.68136.72110.69129.76135.34164.39121.28136.83146.39155.27121.09123.19176.52
Operating Profit 12.3212.166.3122.8323.5821.6918.1614.7319.8517.0914.13-5.2817.76
OPM % 7.80%8.17%5.39%14.96%14.84%11.66%13.02%9.72%11.94%9.92%10.45%-4.48%9.14%
Other Income 2.223.782.390.132.439.672.631.000.173.262.560.030.07
Interest 2.241.781.831.942.242.592.182.232.162.772.542.092.67
Depreciation 3.163.243.262.773.273.593.873.854.003.874.264.284.42
Profit before tax 9.1410.923.6118.2520.5025.1814.749.6513.8613.719.89-11.6210.74
Tax % 23.96%26.37%22.99%24.55%23.02%26.01%24.69%23.42%24.96%29.39%24.67%-14.63%13.04%
Net Profit 6.958.042.7713.7715.7918.6211.107.3810.409.687.45-9.929.34
EPS in Rs 1.441.670.572.863.283.862.301.532.162.011.54-2.061.94

Last Updated: February 5, 2026, 6:16 am

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: February 24, 2026, 7:16 pm

MetricMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025TTM
Sales 303326296310313358360492478551615630620
Expenses 260294266274283312313410390499540557576
Operating Profit 43313036314647828752747344
OPM % 14%10%10%12%10%13%13%17%18%9%12%12%7%
Other Income 2-4811193-0181131546
Interest 141313149996569910
Depreciation 1310889910101113131617
Profit before tax 17-391125233228838236685223
Tax % 0%0%0%20%10%24%26%26%25%24%25%26%
Net Profit 17-391120202421626127513917
EPS in Rs 4.40-9.522.484.604.745.554.8614.2412.665.6510.577.993.43
Dividend Payout % 0%0%0%0%0%0%0%21%24%53%28%38%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year2014-20152015-20162016-20172017-20182018-20192019-20202020-20212021-20222022-20232023-20242024-2025
YoY Net Profit Growth (%)-329.41%128.21%81.82%0.00%20.00%-12.50%195.24%-1.61%-55.74%88.89%-23.53%
Change in YoY Net Profit Growth (%)0.00%457.62%-46.39%-81.82%20.00%-32.50%207.74%-196.85%-54.12%144.63%-112.42%

Kopran Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.

Growth

Compounded Sales Growth
10 Years:7%
5 Years:12%
3 Years:10%
TTM:-2%
Compounded Profit Growth
10 Years:10%
5 Years:12%
3 Years:-14%
TTM:-41%
Stock Price CAGR
10 Years:14%
5 Years:18%
3 Years:-2%
1 Year:-51%
Return on Equity
10 Years:13%
5 Years:12%
3 Years:8%
Last Year:8%

Last Updated: September 5, 2025, 9:15 am

Balance Sheet

Last Updated: December 4, 2025, 1:32 am

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Sep 2025
Equity Capital 39414343434343434848484848
Reserves 67495781101125146202378391443470453
Borrowings 13786809589978866757599148157
Other Liabilities 56998478828592128110135153178155
Total Liabilities 299275264298315351370439611650743844813
Fixed Assets 105102101104104113111112151165182208235
CWIP 2013610243043367097113114
Investments 1000000000000
Other Assets 174172160187201214229284425415465522465
Total Assets 299275264298315351370439611650743844813

Reserves and Borrowings Chart

Cash Flow

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Cash from Operating Activity + 346291626253160-33344342
Cash from Investing Activity + -9-10-9-18-11-25-13-25-84-13-44-56
Cash from Financing Activity + 7-37-192-15-1-18-35123-20126
Net Cash Flow 0-00-0-0-00052111
Free Cash Flow -63518-014-61743-76-27-13-17
CFO/OP 7%147%95%47%94%63%82%93%-17%90%77%76%

Free Cash Flow

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Free Cash Flow-94.00-55.00-50.00-59.00-58.00-51.00-41.0016.0012.00-23.00-25.00-75.00

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Debtor Days 689170867588948997108126125
Inventory Days 10378119122138129154121202133126153
Days Payable 691191159511890951048489103108
Cash Conversion Cycle 101507411396127153106215152149170
Working Capital Days 459344360707981158139131113
ROCE %14%14%14%19%14%16%14%30%21%8%14%10%

Financial Efficiency Indicators Chart

Share Holding Pattern

MonthMar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Promoters 44.29%44.49%44.49%44.49%44.49%44.49%44.49%44.45%44.42%44.43%44.43%44.43%
FIIs 0.41%0.34%0.39%0.48%0.84%0.68%1.31%0.86%1.11%0.76%0.60%0.36%
DIIs 0.14%0.14%0.35%0.14%1.20%0.14%0.22%0.00%0.00%0.00%0.00%0.00%
Public 55.15%55.03%54.78%54.88%53.47%54.68%53.98%54.68%54.45%54.81%54.99%55.21%
No. of Shareholders 41,56744,03853,79151,63650,85051,49257,15460,56058,65260,19462,22260,886

Shareholding Pattern Chart

No. of Shareholders

Kopran Ltd: Intrinsic Value & Share Price Analysis - Shareholder trend analysis

Mutual Fund Holdings

Fund NameNo of SharesAUM (%)Amount Invested (Cr)Previous Number of SharesPrevious DatePercentage Change
Quant Healthcare Fund 101,067 1.41 2.28101,0672025-04-22 17:25:280%
Motilal Oswal S&P BSE Healthcare ETF 251 0.07 0.012512025-04-22 17:25:280%

ROCE Trend

EPS Trend

Key Financial Ratios

MonthMar 25Mar 24Mar 23Mar 22Mar 21
FaceValue 10.0010.0010.0010.0010.00
Basic EPS (Rs.) 7.9910.575.6513.7714.24
Diluted EPS (Rs.) 7.9910.575.6513.7714.24
Cash EPS (Rs.) 11.2113.248.2914.9616.60
Book Value[Excl.RevalReserv]/Share (Rs.) 107.35101.9091.1188.4056.65
Book Value[Incl.RevalReserv]/Share (Rs.) 107.35101.9091.1188.4056.65
Revenue From Operations / Share (Rs.) 130.39127.48114.2999.05113.71
PBDIT / Share (Rs.) 15.9218.4711.3820.3323.07
PBIT / Share (Rs.) 12.6915.798.7418.0220.71
PBT / Share (Rs.) 10.7614.017.4816.9619.27
Net Profit / Share (Rs.) 7.9810.575.6512.6614.24
NP After MI And SOA / Share (Rs.) 7.9810.575.6512.6614.24
PBDIT Margin (%) 12.2114.489.9520.5220.28
PBIT Margin (%) 9.7312.387.6418.1918.21
PBT Margin (%) 8.2510.996.5417.1216.94
Net Profit Margin (%) 6.128.294.9412.7812.52
NP After MI And SOA Margin (%) 6.128.294.9412.7812.52
Return on Networth / Equity (%) 7.4310.376.1914.3225.14
Return on Capital Employeed (%) 11.0414.518.9118.9132.14
Return On Assets (%) 4.566.854.199.9914.02
Long Term Debt / Equity (X) 0.030.030.040.040.08
Total Debt / Equity (X) 0.280.200.170.170.26
Asset Turnover Ratio (%) 0.790.880.870.450.64
Current Ratio (X) 1.762.082.252.741.72
Quick Ratio (X) 1.181.441.521.751.10
Inventory Turnover Ratio (X) 4.092.932.291.821.81
Dividend Payout Ratio (NP) (%) 37.5128.3853.1010.6210.53
Dividend Payout Ratio (CP) (%) 26.7122.6536.208.999.03
Earning Retention Ratio (%) 62.4971.6246.9089.3889.47
Cash Earning Retention Ratio (%) 73.2977.3563.8091.0190.97
Interest Coverage Ratio (X) 8.2310.369.0219.1515.99
Interest Coverage Ratio (Post Tax) (X) 5.136.935.4812.9310.87
Enterprise Value (Cr.) 967.401330.79595.141372.72511.32
EV / Net Operating Revenue (X) 1.542.171.082.871.04
EV / EBITDA (X) 12.5814.9510.8514.015.13
MarketCap / Net Operating Revenue (X) 1.342.030.962.840.92
Retention Ratios (%) 62.4871.6146.8989.3789.46
Price / BV (X) 1.632.541.213.191.85
Price / Net Operating Revenue (X) 1.342.030.962.840.92
EarningsYield 0.040.040.050.040.13

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

About the Company - Qualitative Analysis

Kopran Ltd. is a Public Limited Listed company incorporated on 26/04/1958 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is L24230MH1958PLC011078 and registration number is 011078. Currently Company is involved in the business activities of Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids; chemically pure suger etc.. Company's Total Operating Revenue is Rs. 271.01 Cr. and Equity Capital is Rs. 48.29 Cr. for the Year ended 31/03/2025.
INDUSTRYADDRESSCONTACT
PharmaceuticalsParijat House, 1076, Dr. E. Moses Road, Mumbai Maharashtra 400018Contact not found
Management
NamePosition Held
Mr. Susheel G SomaniChairman
Mr. Surendra SomaniExecutive Vice Chairman
Mr. Adarsh SomaniDirector
Mr. Varun SomaniDirector
Dr. Siddhan SubramanianIndependent Director
Dr. Sunita BanerjiIndependent Director
Mrs. Mamta BiyaniIndependent Director
Mr. Narayan AtalIndependent Director

FAQ

What is the intrinsic value of Kopran Ltd and is it undervalued?

As of 11 April 2026, Kopran Ltd's intrinsic value is ₹114.92, which is 3.43% lower than the current market price of ₹119.00, suggesting the stock is overvalued. This is calculated using the PE ratio method factoring in ROE (7.64 %), book value (₹104), dividend yield (2.53 %), and 5-year EPS CAGR.

What is the current share price and 52-week range of Kopran Ltd?

Kopran Ltd is trading at ₹119.00 as of 11 April 2026, with a FY2026-2027 high of ₹215 and low of ₹107. The stock is currently near its 52-week low. Market cap stands at ₹574 Cr..

How does Kopran Ltd's P/E ratio compare to its industry?

Kopran Ltd has a P/E ratio of 34.7, which is below the industry average of 53.84. This is broadly in line with or below the industry average.

Is Kopran Ltd financially healthy?

Key indicators for Kopran Ltd: ROCE of 9.75 % is on the lower side compared to the industry average of 16.35%; ROE of 7.64 % is below ideal levels (industry average: 15.16%). Dividend yield is 2.53 %.

Is Kopran Ltd profitable and how is the profit trend?

Kopran Ltd reported a net profit of ₹39 Cr in Mar 2025 on revenue of ₹630 Cr. Compared to ₹61 Cr in Mar 2022, the net profit shows a declining trend.

Does Kopran Ltd pay dividends?

Kopran Ltd has a dividend yield of 2.53 % at the current price of ₹119.00. This is a relatively attractive yield for income-seeking investors.

Disclaimer: This article is for informational purposes only and should not be construed as financial advice. The author is not a SEBI registered financial advisor and does not have any vested interest in Kopran Ltd. Investors are advised to conduct their own due diligence and consult with a financial professional before making any investment decisions. The information provided in this article is based on publicly available data and the author's analysis, but it may not be comprehensive or up-to-date. The author and getaka.co.in are not responsible for any errors or omissions in the content. This article is not intended to promote any particular investment strategy or recommendation, and readers should consult with their own financial advisors before making any investment decisions. Data Source: NSE
Explore Industry-wise Stock Analysis Reports